The circadian rhythm hypothesis of bipolar disorder (BD) suggests a role for melatonin in regulating mood, thus extending the interest toward the melatonergic antidepressant agomelatine as well as type I (acute) or II cases of bipolar depression.
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study / Fornaro, M., Mccarthy, M.J., De Berardis, D., De Pasquale, C., Tabaton, M., Martino, M., Colicchio, S., Cattaneo, C.I., D'Angelo, E., Fornaro, P.. - In: NEUROPSYCHIATRIC DISEASE AND TREATMENT. - ISSN 1176-6328. - 9:(2013), p. 243-51. [10.2147/NDT.S41557]
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
Fornaro, Michele;De Pasquale, Concetta;Martino, Matteo;
2013
Abstract
The circadian rhythm hypothesis of bipolar disorder (BD) suggests a role for melatonin in regulating mood, thus extending the interest toward the melatonergic antidepressant agomelatine as well as type I (acute) or II cases of bipolar depression.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Full-text FINALE.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
694.1 kB
Formato
Adobe PDF
|
694.1 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
